A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Recruiting · NCT06624644 · Registry updated 2026-04-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, cutaneous melanoma, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Phase 2 / Phase 3 | 2026-04-22 | NCT06624644 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Linnaeus Therapeutics, Inc. | 2 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana Farber | Boston | United States | 3 |
| Moffitt Cancer Center | Tampa | United States | 1 |
| Stanford | Stanford | United States | 4 |
| UCSF | San Francisco | United States | 27 |
| University of Colorado | Denver | United States | 5 |
| University of Colorado Anschutz | Aurora | United States | 30 |
| University of New Mexico | Albuquerque | United States | 17 |
| UPenn | Philadelphia | United States | 1 |
| USC Newport Beach | Newport Beach | United States | 1 |